Emerging Market Offering CDI specializes in anatomical pathology products including surgical pathology, histology, cytology, and immunohistochemistry, presenting cross-sell opportunities to labs and hospitals upgrading diagnostic workflows with multi-dye systems and margin marking capabilities.

7-Dye System Advantage The launch of the first commercially available 7-dye color system creates a unique selling proposition that can be promoted to expand CDI’s footprint in pathology labs seeking advanced margin marking and tissue identification solutions.

Acquisition Momentum Recent acquisition of Anatech Ltd. signals growth and broader product integration potential, enabling cross-sell to Anatech’s customer base and expanded distribution in strategic regions.

Global Reach With over 6,000 customers in more than 50 countries, CDI has established international demand that sales teams can target for expansion, channel partnerships, and localized support packages.

Growth Readiness Financially, CDI operates in a $1M-$10M revenue band with scalable product lines and a lean team; this presents upsell opportunities to larger institutions and mid-sized laboratories seeking comprehensive pathology solutions.